Hannah A. Hathaway, Ph.D.

Affiliations: 
2014 Pharmacology Georgetown University, Washington, DC 
Area:
Neuropharmacology, glutamate receptors
Google:
"Hannah Hathaway"
Mean distance: 17.08 (cluster 6)
 
SNBCP

Parents

Sign in to add mentor
Jarda T. Wroblewski grad student 2014 Georgetown
 (Function and signal transduction of metabotropic glutamate receptor 1 in cerebellar granule cells.)
Wendy B. Macklin post-doc University of Colorado, Denver
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gelb T, Pshenichkin S, Hathaway HA, et al. (2015) Atypical signaling of metabotropic glutamate receptor 1 in human melanoma cells. Biochemical Pharmacology. 98: 182-9
Hathaway HA, Pshenichkin S, Grajkowska E, et al. (2015) Pharmacological characterization of mGlu1 receptors in cerebellar granule cells reveals biased agonism. Neuropharmacology. 93: 199-208
Gelb T, Pshenichkin S, Rodriguez OC, et al. (2015) Metabotropic glutamate receptor 1 acts as a dependence receptor creating a requirement for glutamate to sustain the viability and growth of human melanomas. Oncogene. 34: 2711-20
Gelb T, Hathaway HA, Wroblewski JT. (2014) Triple threat treatment: Exploiting the dependence receptor properties of metabotropic glutamate receptor 1 against melanoma. Molecular & Cellular Oncology. 1: e969163
DiRaddo JO, Miller EJ, Hathaway HA, et al. (2014) A real-time method for measuring cAMP production modulated by Gαi/o-coupled metabotropic glutamate receptors. The Journal of Pharmacology and Experimental Therapeutics. 349: 373-82
Béraud D, Hathaway HA, Trecki J, et al. (2013) Microglial activation and antioxidant responses induced by the Parkinson's disease protein α-synuclein. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 8: 94-117
Emery AC, DiRaddo JO, Miller E, et al. (2012) Ligand bias at metabotropic glutamate 1a receptors: molecular determinants that distinguish β-arrestin-mediated from G protein-mediated signaling. Molecular Pharmacology. 82: 291-301
See more...